To figure out the underlying mechanism of KD affecting liver cancer cell growth, we measured insulin secretion by ELISA in pancreatic β cells cultured in the BHB-Glow medium KD and found that insulin content was significantly decreased in the ketogenic group versus control group (Figure 3A). The gene discussed is INS; the disease is liver cancer.